Belite Bio (BLTE) Institutional Ownership $58.38 +3.69 (+6.75%) Closing price 04:00 PM EasternExtended Trading$58.38 0.00 (0.00%) As of 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Belite Bio (NASDAQ:BLTE)CurrentInstitutional OwnershipPercentage0.53%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$16.76MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$470.86K Get BLTE Insider Trade Alerts Want to know when executives and insiders are buying or selling Belite Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLTE Institutional Buying and Selling by Quarter Belite Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/15/2025 GAMMA Investing LLC1,849$122K0.0%+43.3%0.006% 4/7/2025 GAMMA Investing LLC122,441$8.11M0.0%+9,391.6%0.385% 2/17/2025Citadel Advisors LLC5,211$329K0.0%-19.3%0.017% 2/17/2025Bank of America Corp DE18,342$1.16M0.0%+36.4%0.059% 2/17/2025BNP Paribas Financial Markets2,450$155K0.0%N/A0.008% 2/14/2025Virtus ETF Advisers LLC1,122$71K0.0%-39.1%0.004% 2/13/2025Marshall Wace LLP5,865$370K0.0%-30.9%0.018% 2/13/2025XTX Topco Ltd7,062$446K0.0%+30.9%0.022% 2/12/2025JPMorgan Chase & Co.14,636$924K0.0%+130.3%0.047% 1/28/2025Advisors Preferred LLC798$52K0.0%N/A0.003% Get the Latest News and Ratings for BLTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. 1/3/2025 GAMMA Investing LLC1,290$81K0.0%+48.1%0.004% 12/26/2024JPMorgan Chase & Co.6,356$298K0.0%+7,122.7%0.021% 11/15/2024XTX Topco Ltd5,394$253K0.0%N/A0.018% 11/15/2024State Street Corp20,086$942K0.0%+28.2%0.066% 11/15/2024Point72 Asset Management L.P.4,800$225K0.0%-34.3%0.016% 10/7/2024 GAMMA Investing LLC871$41K0.0%+103.5%0.003% 8/19/2024Point72 Asset Management L.P.7,311$334K0.0%-16.0%0.025% 8/15/2024Armistice Capital LLC148,000$6.76M0.1%N/A0.497% 2/13/2024Armistice Capital LLC36,000$1.65M0.0%N/A0.130% 2/7/2024Jump Financial LLC5,200$238K0.0%N/A0.019% 11/8/2023Atria Wealth Solutions Inc.74,019$2.36M0.0%-90.9%0.272% 8/3/2023Atria Wealth Solutions Inc.814,498$11.64M0.2%+0.3%3.268% 2/13/2023Atria Wealth Solutions Inc.811,765$24.47M0.4%+1,397.6%3.264% 11/3/2022Barclays PLC6,661$223K0.0%N/A0.027% 8/15/2022Atria Wealth Solutions Inc.49,463$1.54M0.0%N/A0.199% (Data available from 1/1/2016 forward) BLTE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLTE shares? During the previous two years, 14 institutional investors and hedge funds held shares of Belite Bio. The most heavily invested institutionals were Armistice Capital LLC ($6.76M), Atria Wealth Solutions Inc. ($2.36M), Bank of America Corp DE ($1.16M), State Street Corp ($942K), JPMorgan Chase & Co. ($924K), XTX Topco Ltd ($446K), and Marshall Wace LLP ($370K).Learn more on BLTE's institutional investors. What percentage of Belite Bio stock is owned by institutional investors? 0.53% of Belite Bio stock is owned by institutional investors. Learn more on BLTE's institutional investor holdings. Which institutional investors have been buying Belite Bio stock? Of the 10 institutional investors that purchased Belite Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($184K), GAMMA Investing LLC ($122.57K), JPMorgan Chase & Co. ($14.55K), XTX Topco Ltd ($7.06K), Jump Financial LLC ($5.20K), Bank of America Corp DE ($4.89K), and State Street Corp ($4.42K). How much institutional buying is happening at Belite Bio? Institutional investors have bought a total of 348,669 shares in the last 24 months. This purchase volume represents approximately $18.69M in transactions. Which Belite Bio major shareholders have been selling company stock? The following institutional investors have sold Belite Bio stock in the last 24 months: Atria Wealth Solutions Inc. ($740.48K), Point72 Asset Management L.P. ($3.90K), Marshall Wace LLP ($2.62K), Citadel Advisors LLC ($1.25K), and Virtus ETF Advisers LLC ($721.00). How much institutional selling is happening at Belite Bio? Institutional investors have sold a total of 748,970 shares in the last 24 months. This volume of shares sold represents approximately $24.06M in transactions. Related Companies ROIV Major Shareholders LNTH Major Shareholders RVMD Major Shareholders BBIO Major Shareholders TGTX Major Shareholders LEGN Major Shareholders SRPT Major Shareholders BPMC Major Shareholders AXSM Major Shareholders NUVL Major Shareholders This page (NASDAQ:BLTE) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrade War Just Turned 3 Unknown Stocks Into Rocket FuelThe Real Catalyst Behind America’s Next Bull Run One overlooked sector is being completely repriced — and s...Insiders Exposed | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLTE Stock Free BLTE Stock Alerts